Testing OM-89 to reduce antibiotic use for UTIs in neurogenic bladder
Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a medication called OM-89 (a bacterial extract taken by mouth) can help reduce how often you need antibiotics for urinary tract infections (UTIs). It is for people with a neurogenic bladder from a spinal cord injury who use a catheter to empty their bladder and have had many UTIs in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a neurogenic bladder (bladder control issues) due to a spinal cord injury that has been stable for over 2 years.
- You use clean intermittent catheterization (a tube to empty your bladder) 5 to 6 times a day.
- You have had at least 6 antibiotic treatments for urinary tract infections in the last 12 months.
- You do not have any allergies to the study medication OM-89, and you are not currently using any other treatments for urinary tract infections.
- You are not pregnant (if you could become pregnant) and agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks patients and caregivers about their experiences with bladder washes (instillations) using lactobacillus or gentamicin to manage urinary symptoms. Your feedback could help improve care for others like you.
This study tests whether taking an antibiotic (ciprofloxacin) around the time of bladder Botox can prevent urinary tract infections (UTIs) in people whose bladder problems are caused by nerve conditions. It may help lower the chance of infection after treatment.
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
This study looks at whether giving antibiotics (or not) before bladder Botox injections can reduce later urinary infections in people with nerve-related bladder problems. It focuses on people who have bacteria in the urine but no symptoms, using bladder self-catheterization as their main bladder management.
This early-stage trial tests a new treatment combining an antibiotic (gentamicin) and beneficial bacteria (lactobacillus) instilled directly into the bladder to help prevent urinary tract infections in people with neurogenic bladder—a condition where nerve damage affects bladder control. The goal is to see if this approach is safe and helps reduce infection risk.
This trial studies a new way to help stop urinary tract infections (UTIs) from coming back by using “bacterial interference” (changing the bacteria in the urinary system). It may help people who have had UTIs keep returning despite past treatments.
Hear when a new Neurogenic Bladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.